Sanofi Ventures is the corporate venture capital arm of Sanofi, investing in early-stage biotech and digital health companies focused on transforming healthcare. It invests across therapeutic areas including immunology, oncology, rare diseases, vaccines, and data science.
51% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $121.7M (across 148 rounds with reported amounts).
Portfolio
113
Fund Size
$625M
Top Stage
Series B
Last 12 Mo
21
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
166 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 OMass Therapeutics | Series C | $310M | Oct 2026 |
 Agomab Therapeutics | Series D | $89M | Sep 2026 |
 Epicrispr Biotechnologies | Series C | $90M | Aug 2026 |
 Quant Health | Series B | $45M | Aug 2026 |
 Draig Therapeutics | Series B | $65M | Jul 2026 |
| CCour Pharma | Series B | $50M | Jun 2026 |
 BranchLab | Seed | $26M | May 2026 |
 Windward Bio | Unknown | $165M | May 2026 |
 Windward | Unknown | $165M | May 2026 |
 Alveus Therapeutics Inc | Series A | $37M | Feb 2026 |
| AAltesa Biosciences | Series B | $75M | Feb 2026 |
| AAltesa | Series B | $75M | Feb 2026 |
 QuantX Biosciences | Series B | $85M | Feb 2026 |
| QQuantX | Series B | $85M | Feb 2026 |
 Mirador | Series B | $250M | Jan 2026 |
| Alveus Therapeutics Inc | Series A | $160M | Jan 2026 |
 Enable Injections | Seed | $30M | Jan 2026 |
| BranchLab | Series A | $26M | Jan 2026 |
 Memento Medicines | Series A | $93M | Jan 2026 |
 Earendil | Unknown | $787M | Jan 2026 |
 GluBio Pharmaceutical | Seed | $20M | Jan 2026 |
| CCour Pharma | Series B | $50M | Jan 2026 |
| EEarendil Labs | Unknown | $787M | Jan 2026 |
| QQuantX | Series B | $130M | Jan 2026 |
| QuantX Biosciences | Series B | $85M | Jan 2026 |
Page 1 of 7
Top Co-Investors
RA Capital Management28 shared
OrbiMed27 shared
Novo Capital17 shared
Cormorant Asset Management15 shared
Redmile Group14 shared
Forbion13 shared
Andreessen Horowitz12 shared
Sofinnova Partners12 shared
Novo Holdings A/S12 shared
Alexandria Venture Investments11 shared
Blue Owl Healthcare Opportunities11 shared
Samsara BioCapital11 shared
GV10 shared
EQT Life Sciences10 shared
Fidelity Investments10 shared
Atlas Venture10 shared
Logos Capital10 shared
SV Health Investors10 shared
FPV Ventures9 shared
Thrive Capital9 shared
Last updated: 20 October 2026